Michael Jacobsen

Director of Finance/CFO at OMEROS CORPORATION

Net worth: 42 840 $ as of 2024-04-29

65 year

Health Technology

Consumer Services

Michael Jacobsen active positions

Companies	Position	Start	End
OMEROS CORPORATION	Comptroller/Controller/Auditor	2013-09-30	-
	Director of Finance/CFO	2013-07-31	-
	Treasurer	2013-09-30	-

Companies	Position	Start	End
SAREPTA THERAPEUTICS, INC.	Comptroller/Controller/Auditor	2011-09-07	-
	Director of Finance/CFO	2011-09-08	2011-11-14
	Corporate Officer/Principal	2011-09-07	2011-09-07
	Corporate Secretary	2011-09-06	2013-04-21
ZymoGenetics, Inc. ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA.	Chief Operating Officer	2007-03-31	2011-07-31
ICOS Corp. ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA.	Comptroller/Controller/Auditor	-	-
	Director of Finance/CFO	-	-

Idaho State University

Undergraduate Degree

International

United States

Operational

Comptroller/Controller/Auditor	3
Director of Finance/CFO	3
Corporate Officer/Principal	1

Sectoral

Health Technology	5
Consumer Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	2
SAREPTA THERAPEUTICS, INC.	Health Technology
OMEROS CORPORATION	Health Technology

Private companies	2
ICOS Corp. ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA.	Health Technology
ZymoGenetics, Inc. ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA.	Health Technology

Private companies

Health Technology